Government urged to boost domestic R&D field via tax breaks, etc.

Published: 2003-08-20 06:59:00

Updated: 2003-08-20 06:59:00

As part of measures to gear up the domestic pharmaceutical companies' competitiveness in the global BT sector, the government should push up with a variety of R&D investment stimulus measures including more tax benefits and flexible price management of drugs, according to pharmaceutical sources.
...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK